| Pancreatic iron and glucose dysregulation in thalassemia major. | |
| | |
MedLine Citation:
|
PMID: 22120775 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Pancreatic iron overload and diabetes mellitus (DM) are common in thalassemia major patients. However, the relationship between iron stores and glucose disturbances is not well defined. We used a frequently sampled oral glucose tolerance test (OGTT), coupled with mathematical modeling, and magnetic resonance imaging (MRI) to examine the impact of pancreatic, cardiac, and hepatic iron overload on glucose regulation in 59 patients with thalassemia major. According to OGTT results, 11 patients had DM, 12 had impaired glucose tolerance (IGT), 8 had isolated impaired fasting glucose (IFG), and 28 patients had normal glucose tolerance (NGT). Patients with DM had significantly impaired insulin sensitivity and insulin release. Insulin resistance was most strongly associated with markers of inflammation and somatic iron overload, while disposition index (DI) (a measure of beta cell function) was most strongly correlated with pancreas R2*. Patients with DM and IGT had significantly worse DI than those with NGT or IFG, suggesting significant beta cell toxicity. One-third of patients having elevated pancreas R2* had normal glucose regulation (preclinical iron burden), but these patients were younger and had lower hepatic iron burdens. Our study indicates that pancreatic iron is the strongest predictor of beta cell toxicity, but total body iron burden, age, and body habitus also influence glucose regulation. We also demonstrate that MRI and fasting glucose/insulin are complementary screening tools, reducing the need for oral glucose tolerance testing, and identify high-risk patients before irreversible pancreatic damage. Am. J. Hematol., 2011. © 2011 Wiley Periodicals, Inc. |
| | |
Authors:
|
Leila J Noetzli; Steven D Mittelman; Richard M Watanabe; Thomas D Coates; John C Wood |
Related Documents
:
|
1856575 - Lipoprotein composition and hdl particle size distribution in women with non-insulin-de... 11877595 - A patient with apolipoprotein e2 variant (q187e) without lipoprotein glomerulopathy. 8866565 - Metabolic consequences of a family history of niddm (the botnia study): evidence for se... 1982815 - The impact of capd treatment on lipid metabolism and cardiovascular risk. 7544105 - Artifactual hypoglycemia associated with hematopoietic cytokines. 2094745 - Anticonvulsant syndrome with multiple symptoms, including porphyria, iga deficiency, an... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-10-20 |
Journal Detail:
|
Title: American journal of hematology Volume: - ISSN: 1096-8652 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-11-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7610369 Medline TA: Am J Hematol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Wiley Periodicals, Inc. |
Affiliation:
|
Department of Pediatrics, Division of Cardiology, Children's Hospital Los Angeles, Los Angeles, California. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteos...
Next Document: Heavy metal pattern and solute concentration in soils along the oldest highway of the world - the AV...